Ankerst, Donna P.
Prostate Cancer Screening
I. Trends in Prostate Cancer Screening
1. Overview of US Prostate Cancer Trends in the Era of PSA Screening
Ruth Etzioni, Roman Gulati, Angela Mariotto
2. Trends in Prostate Cancer Screening: Overview of the UK
Richard J. Bryant, Freddie C. Hamdy
3. Trends in Prostate Cancer Screening: Canada
Robert K. Nam, Laurence H. Klotz
4. Trends in Prostate Cancer Screening – Overview of Europe
Sanjai K. Addla, Bob Djavan
II. Prostate-Specific Antigen
5. Evolution of Prostate-Specific Antigen for Screening
Javier Hernandez, Edith Canby-Hagino
6. The Performance Characteristics of Prostate-Specific Antigen for Prostate Cancer Screening
Ian M. Thompson, Donna P. Ankerst
7. The Performance of PSA for Predicting Prostate Cancer After a Prior Negative Prostate Biopsy
Catherine M. Tangen
8. Subfractions and Derivatives of Total Prostate-Specific Antigen in the Early Detection of Prostate Cancer
Alexander Haese, Alan W. Partin
9. PSA Velocity at Presentation as a Predictor of Prostate Cancer Aggressiveness
Jason A. Efstathiou, Anthony V. D’Amico
III. Risk Assessment for Prostate Cancer
10. Nomograms for Prostate Cancer
Shahrokh F. Shariat, Michael W. Kattan
11. Decision Aid Criteria and Artificial Neural Networks for Optimizing Prostate Cancer Risk Prediction
Felix K.-H. Chun, Pierre I. Karakiewicz
12. Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator
Donna P. Ankerst, Ian M. Thompson
13. Integration of Risk Assessment in Prostate Cancer Screening
Kadee E Thompson, Amanda Reed, Dipen J Parekh
14. Family History of Prostate Cancer During Rapidly Increasing Incidence
Kari Hemminki, Justo Lorenzo Bermejo
IV. Recent Biomarkers for Prostate Cancer
15. PSA Isoforms: [-2]proPSA Significant Adjunct to Free PSA
Jeffrey E. Tam
16. PCA3
Jack Groskopf, Jack Schalken, Harry Rittenhouse
17. Transcriptional Profiling of Prostate Cancer: Biomarker Identification and Clinical Applications
Nigel Clegg, Peter S. Nelson
18. Biomarkers for Prostate Cancer Detection: Family-Based Linkage Analysis and Case–Control Association Studies
Joke Beuten, Teresa L Johnson-Pais
19.
Rui Henrique, Carmen Jerónimo
20. EPCA and EPCA-2 as Potential Biomarkers for Prostate Cancer Detection
Eddy S. Leman, Robert H. Getzenberg
V. Design and Methodologic Considerations in Biomarker Studies
21. Toward a Robust System for Biomarker Triage and Validation – EDRN Experience
Ziding Feng, Jacob Kagan, Sudhir Srivastava
22. Statistical Evaluation of Markers and Risk Tools for Prostate Cancer Classification and Prediction
Yingye Zheng, Donna P. Ankerst
23. Pitfalls in Prostate Cancer Biomarker Evaluation Studies
Donna P. Ankerst
VI. Building upon Recently Completed and Ongoing Prospective Trials
24. Prostate-Specific Antigen and Its Role on the Prostate Cancer Prevention Trial
Catherine M. Tangen, Phyllis J. Goodman
25. The Selenium and Vitamin E Cancer Prevention Trial
Eric A. Klein
26. PLCO: A Randomized Controlled Screening Trial for Prostate, Lung, Colorectal, and Ovarian Cancer
Amanda Black, Robert L. Grubb, E David Crawford
27. The European Randomized Study of Screening for Prostate Cancer (ERSPC)
Tineke Wolters, Fritz H. Schröder
Nyckelord: MEDICAL / Public Health MED078000
- Författare
- Ankerst, Donna P.
- Tangen, Catherine M.
- Thompson, Ian M.
- Utgivare
- Springer
- Utgivningsår
- 2009
- Språk
- en
- Utgåva
- 1
- Serie
- Current Clinical Urology
- Sidantal
- 413 sidor
- Kategori
- Hälsa, skönhet, mode
- Format
- E-bok
- eISBN (PDF)
- 9781603272810